Chen, S <br/><br/>
The predictive and prognostic significance of pre- and post-treatment topoisomerase IIα in anthracycline-based neoadjuvant chemotherapy for local advanced breast cancer.  [electronic resource] 

 -  European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology  Jun 2013 
 - 619-26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-2157 
<br/><br/><label>Standard No.: </label>10.1016/j.ejso.2013.02.019  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Analysis of Variance<br/>Anthracyclines--administration & dosage<br/>Antigens, Neoplasm--analysis<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>DNA Topoisomerases, Type II--analysis<br/>DNA-Binding Proteins--analysis<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Kaplan-Meier Estimate<br/>Logistic Models<br/>Lymph Node Excision<br/>Mastectomy--methods<br/>Middle Aged<br/>Neoadjuvant Therapy--methods<br/>Predictive Value of Tests<br/>Prognosis<br/>Proportional Hazards Models<br/>Receptor, ErbB-2--analysis<br/>Retrospective Studies